GlassScriptPhysician profile
Ronald A Summers
NPI 1730183559
$1,751.33
in general payments reported to CMS, 2019-2025
19 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $119 · 2021: $113 · 2022: $44.09 · 2023: $309 · 2024: $171 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775 · Travel and Lodging: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.38 |
| Travel and Lodging | $497.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $656.66 | 2019-2025 | Persona, Rosa |
| Ferring Pharmaceuticals INC. | $241.27 | 2019-2023 | Euflexxa |
| Miach Orthopaedics, INC. | $170.92 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $106.72 | 2025 | Journavx |
| Amgen INC. | $96.63 | 2024-2025 | Krystexxa |
| Bioventus LLC | $72.45 | 2020-2023 | Durolane |
| Depuy Synthes Sales INC. | $59.04 | 2024-2025 | Speedtrap, Dynatape, Truespan Orthocord |
| Horizon Therapeutics Plc | $45.44 | 2023 | Krystexxa |
| Arthrex, INC. | $43.32 | 2024 | Arthrex |
| Becton, Dickinson and Company | $43.22 | 2025 | Hemosphere |
| Neurocrine Biosciences, INC. | $36.10 | 2024 | Ingrezza |
| Si-Bone, INC. | $35.28 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $29.79 | 2024 | Uzedy |
| Pacira Pharmaceuticals Incorporated | $28.27 | 2024 | Exparel |
| Ermi LLC | $25.87 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $18.22 | 2022 | |
| Joint Active Systems, INC. | $17.95 | 2021 | |
| Medtronic USA, INC. | $12.18 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.